PharmEasy IPO: Company commited to go public
The IPO chatter comes after a string of corporate moves at API Holdings over the past few years. It acquired diagnostics chain Thyrocare Technologies back in September 2021. More recently, in September 2025, the company raised Rs 1,700 crore through a non-convertible debenture issuance led by 360 ONE and used part of the proceeds to repay about Rs 2,200 crore of secured NCDs owed to Goldman Sachs and EvolutionX. Just this May, the National Company Law Tribunal allowed the initial process for the merger to amalgamate Docon Tech with API Holdings, streamlining its corporate structure further.
